Test Price
1,100 AED✅ Home Collection Available
H9N2 & Influenza A Qualitative RNA Detection Test in UAE | 1100 AED | DHA Guidelines
Executive Summary & Core Metrics
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited Processing (Cert: INT/EGQ/2509DA/3139). Dual-platform verification: Real-Time PCR (qPCR) + Whole Genome Sequencing (WGS).
- Premium Logistics: Hospital-Extraction Only – Sample collection is conducted strictly within an accredited hospital facility; mobile home phlebotomy is disabled for safety. Accepted specimen: sputum, throat and nasal swabs in viral transport medium, lung tissue biopsy, and cell cultures.
- Clinical Guidance: Telephonic post-test clinical correlation with DHA-licensed physicians. Interpretation support in English within 36 hours on phone, 48 hours by email.
- Insurance & Billing: Direct billing verification for all major UAE networks. Send your Emirates ID and insurance card via WhatsApp to +971 54 548 8731 for instant confirmation.
Test Overview & Methodology
This advanced molecular assay simultaneously detects RNA from the H9N2 avian influenza virus and all influenza A subtypes in respiratory specimens using quantitative Real-Time PCR, with confirmatory Whole Genome Sequencing for subtype identification. Designed for rapid differentiation of zoonotic and seasonal infections, it provides actionable results within 36 hours by phone, aligning with DHA respiratory virus surveillance protocols.
| Feature | Our H9N2 & Flu A RNA Test | Standard Rapid Antigen Test |
|---|---|---|
| Precision | 99.9% sensitivity/specificity qPCR + WGS | ~50–70% sensitivity, no subtyping |
| Methodology | Real-Time PCR (NAAT) + Whole Genome Sequencing | Immunochromatographic lateral flow |
| Turnaround Time | Phone: 36 hours | Email: 48 hours (4th working day) | 15–30 minutes (screening only) |
| Subtype Identification | Differentiates H9N2, H1N1, H3N2, etc. with genetic lineage | Influenza A/B without subtype |
Physician Insight & Safety Protocols
“As a Consultant Medical Genetics, I emphasize the value of molecular testing for zoonotic influenza. This qPCR plus WGS platform delivers not just detection but full subtyping, crucial for guiding antiviral therapy and public health response. Please remember that any positive result must be correlated with clinical presentation and exposure history.”
— Lina Osama Zaki Quteineh, Consultant Medical Genetics | DHA ID: 9294403
Medication Advisory
Do not discontinue prescribed medication without consulting your doctor.
Inform our team about any recent antiviral medications, influenza vaccination within 7 days, or anticoagulant therapy if a tissue biopsy is required. Under Federal Decree-Law No. 4 of 2016 on Medical Liability, your consent and safety are our priority.
Safety Exclusion Criteria & Emergency Red Flags
Exclusion Criteria
This test is not suitable for patients unable to provide a respiratory sample (severe respiratory distress requiring immediate clinical stabilization). Hospital extraction will be rescheduled if the patient exhibits signs of acute hypoxia or altered mental status.
ER Red Flags – Seek Immediate Emergency Care if you have:
- Severe shortness of breath, bluish lips or face
- Chest pain or pressure
- Confusion, inability to wake or stay awake
- High fever (>39°C) unresponsive to paracetamol, especially in children
If any of these occur, call 998 for UAE Ambulance Services or proceed to the nearest emergency department.
Patient FAQ & Clinical Guidance
1. What does a positive H9N2 RNA detection mean?
A positive result confirms the presence of H9N2 avian influenza virus RNA in your respiratory sample, indicating active infection. You should isolate immediately, consult your physician for potential antiviral therapy, and notify local health authorities as per UAE communicable disease regulations. Consent and safety protocols follow Federal Decree-Law No. 4 of 2016 on Medical Liability.
2. How should I prepare for the sample collection?
Bring a signed consent form and any available clinical history, including recent travel, poultry exposure, and a list of current medications (especially antivirals or immunosuppressants). Avoid using mouthwash or gargling immediately before providing a throat swab to prevent dilution of viral particles.
3. Is this test suitable for children and what are the DHA guidelines?
Yes, the test is approved for all ages with parental consent required for minors. DHA guidelines mandate molecular confirmation for suspected novel influenza cases, and our hospital-based collection team is trained in pediatric support to ensure a comfortable experience. Data handling complies with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 concerning the use of ICT in health fields.
UAE Regulatory & Data Privacy Adherence
This service operates under the strictest UAE data protection and healthcare regulations. All patient data is processed in accordance with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Genetic and diagnostic information is encrypted, access-controlled, and used solely for clinical decision support. ISO 9001:2015 quality management ensures continuous compliance. DHA Facility License: 1143.
Clinical & Logistical Metadata
| Test Name | H9N2 & Influenza A Qualitative RNA Detection Test |
| Price (AED) | 1100 AED |
| Turnaround Time | Telephonic preliminary report: 36 hours; Final written report: 48 hours (4th working day) |
| Sample Type / Matrix | Hospital Extraction Only – Sample collection is conducted strictly within an accredited hospital facility; mobile home phlebotomy is disabled for safety. Accepted specimen: sputum, throat and nasal swabs in viral transport medium, lung tissue biopsy, and cell cultures. |
| Methodology Used | Real-Time PCR (qPCR) with confirmatory Whole Genome Sequencing (WGS) for subtype identification |
| ICD-10-CM Code | J09 (Influenza due to identified novel influenza A virus), J10.1 (Influenza due to other identified influenza virus with other respiratory manifestations) |
| LOINC Code | 104161-3 (Influenza virus A subtype H9N2 RNA [Presence] in Specimen by NAA with probe detection), 45238-6 (Influenza virus A RNA [Presence] in Specimen by NAA with probe detection) |
| DHA Facility License & Laboratory Address | DHA Facility License Number: 1143 | Laboratory Address: Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | Corporate Lab: DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians